{
    "title": "US FDA declines to approve Amneal's Parkinson's drug over safety concerns",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12260161/US-FDA-declines-approve-Amneal-Pharmas-Parkinsons-drug.html",
    "date": "2023-07-03",
    "keywords": [
        "drug",
        "company",
        "safety",
        "fda",
        "disease",
        "response",
        "letter",
        "treatment",
        "decision",
        "amneal",
        "food",
        "administration",
        "duration",
        "aftermarket",
        "trading",
        "health",
        "regulator",
        "doubt",
        "ingredient",
        "carbidopa",
        "component",
        "agency",
        "efficacy",
        "manufacturing",
        "formulation",
        "carbidopalevodopa",
        "standard",
        "care",
        "intestine",
        "period",
        "absorption",
        "surprise",
        "analyst",
        "balaji",
        "launch",
        "half",
        "specialty",
        "business",
        "forecast",
        "revenue",
        "rytary",
        "market",
        "foothold",
        "space",
        "approval",
        "brain",
        "disorder",
        "cure",
        "raghav",
        "mahobe",
        "khushi",
        "mandowara",
        "roy",
        "bengaluru",
        "editing",
        "pooja",
        "desai",
        "shweta",
        "agarwal",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}